PROGRAMMA SCIENTIFICO
XXXIX CONGRESSO NAZIONALE AISP (Associazione Italiana per lo Studio del Pancreas)
VENERDÌ 23 OTTOBRE 2015
Sala Blu 1
Ore 08.30-09.00
INAUGURAZIONE
F. Corcione (NA), G. Delle Fave (RM), M. Montorsi (MI), A. Zerbi (MI)
Ore 09.00-09.30
STUDI AISP
Moderatori: G. Capurso (RM), A. Zerbi (MI)
Linee Guida AISP Pancreatite Acuta
R. Pezzilli (BO)
Trial chemioterapia neoadiuvante
G. Balzano (MI)
Stenting in malattie del pancreas
M. Mutignani (MI)
Trial fluidi nella pancreatite acuta
G. Capurso (RM)
Registro resezioni laparoscopiche del pancreas SICE-AISP
M. Morino (TO)
Discussione
Ore 09.30-11.00
LA PALLIAZIONE DELLE NEOPLASIE PANCREATICHE
Moderatori: G. Boz (PN), A. Repici (MI)
Endoscopia: stent via biliare e duodeno
M. Traina (PA)
Endoscopia: stents EUS guidati
A. Larghi (RM)
Chirurgia
R. Casadei (BO)
La qualità di vita, il dolore, la nutrizione
A. Andriulli (FG)
Chemioterapia
C. Carnaghi (MI)
Radioterapia
A. G. Morganti (BO)
Discussione
Ore 11.00-11.20 Break
Ore 11.20-13.00
TAVOLA ROTONDA
RICERCA TRASLAZIONALE E ADENOCARCINOMA DEL PANCREAS
Moderatori: A. Malesci (MI), A. Scarpa (VR)
La fibrosi: ostacolo o possibile target?
F. Novelli (TO)
Risposta immunitaria
P. Allavena (MI)
Opportunità dai modelli di colture primarie
N. Funel (PI)
Infiammazione e markers diagnostici
D. Basso (PD)
Quale spazio per la Next-Generation Sequencing
L. Laghi (MI)
Perché le target therapy hanno fallito?
E. Raymond (SVIZZERA)
Medicina traslazionale in AISP: scenari possibili, una piattaforma comune?
L. Piemonti (MI)
Discussione
Ore 13.00-13.30
SIMPOSIO CONGIUNTO AISP-SID
IL CROSS-TALK ACINO-INSULA
Moderatori: G. Delle Fave (RM), F. Marotta (MI)
Il punto di vista del diabetologo
P. Marchetti (PI)
Il punto di vista del gastroenterologo
R. Pezzilli (BO)
Discussione
Ore 13.30-14.30 Pausa pranzo & Poster round
Moderatori: G. Capurso (RM), S. Crippa (MI)
Ore 14.30-15.30
COMUNICAZIONI ORALI
Scienza di base
Moderatori: P. Fogar (PD), A. Gabbrielli (VR)
Association of AKT1 and SELP Polymorphisms with Cachexia and Survival of Patients with Pancreatic
Cancer
Pacetti
Blood expression of Matrix Metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9
supports diagnosis and prognosis of PDAC-associated Diabetes Mellitus
S. Moz (PD)
Pancreatic Stellate Cells promote pluripotency in pancreatic cancer cells
Picariello
Combined inhibition of IL¬1, CXCR1/2, and TGFβ signaling pathways modulates in vivo acquired
resistance to anti¬ VEGF treatment.
Carbone
ZEB1 Regulates DNA Damage Response During Gemcitabine Treatment in PDACs Cells
I. Passacantilli (RM)
TGF-β/EGFR AUTOCRINE CROSS-TALK AFFECTS EMT PROCESS AND MIGRATION IN 3D TISSUEENGENEERED MODEL OF PANCREATIC DUCTAL ADENOCARCINOMA
N. Funel (PI)
Epithelial-to-Mesenchymal Transition (EMT) and Pancreatic Cancer progression
M. Tacelli ()
Digital quantification of microRNA in plasma for early diagnosis of pancreatic cancer
F. Tavano (FG)
Ore 15.30-16.30
UTILIZZO DI RMN (risonanza magnetica nucleare) ED EUS (ecoendoscopia) IN SITUAZIONI CLINICHE
PARTICOLARI
Moderatori: L. Calculli (BO), M. Falconi (MI)
Screening cancro familiare: stato dell’arte
J.W. Poley (PAESI BASSI)
Screening cancro familiare: la situazione in Italia
M. Del Chiaro (SVEZIA)
Follow-up IPMN: perché con EUS
S. Carrara (MI)
Follow-up IPMN: perché con MRI
R. Salvia (VR)
Come validare le linee guida italiane: lo studio PANCY
E. Buscarini (CR)
Discussione
Ore 16.30-17.00 Break
Ore 17.00-18.00
COMUNICAZIONI ORALI
Malattie infiammatorie del pancreas
Moderatori: G.M. Cavestro (MI), S. Crippa (MI)
The Risk of Malignancy in 1,712 Patients Resected for Intraductal Papillary Mucinous Neoplasms (IPMN)
of the Pancreas: A Report from the Pancreatic Surgical Consortium
G. Marchegiani (VR)
Low Progression Of Intraductal Papillary Mucinous Neoplasms With Worrisome Features And High-Risk
Stigmata Undergoing Non-Operative Management: A Mid-Term Follow-Up Analysis
S. Crippa (AN)
Value of Magnetic Resonance Diffusion-Weighted Imaging in the Evaluation of Pancreatic
Neuroendocrine Neoplasms
R. De Robertis ()
Prevalence of Chronic Pancreatitis: Preliminary Results of a Primary Care Physicians based PopulationStudy
G. Capurso (RM)
Bile Duct Involvement in Autoimmune Pancreatitis: Clinical Features and Prognostic Aspects in 92
Patients
P. Campagnola ()
Endoscopic Ultrasonography May Select Subjects Having Chronic Asymptomatic Pancreatic
Hyperenzymemia Who Require A More Strict Follow-Up
Antonini
Comparison of Capillary vs Aspiration Technique in Endoscopic Ultrasound-guided Fine Needle
Aspiration (EUS-FNA): a Preliminary Report
Dabizzi
A Multimodal, One-Session Endoscopic Approach for Management of Patients with Advanced
Pancreatic Cancer.
Manta
Ore 18.00-18.30
ASSEMBLEA
SABATO 24 OTTOBRE 2015
Sala Blu 1
Ore 08.30-09.30
LA PANCREASECTOMIA TOTALE
Moderatori: C. Bassi (VR), G. Uomo (NA)
Indicazioni e aspetti chirurgici
P. Di Sebastiano (CH)
La gestione dell’insufficienza esocrina totale
M. Piciucchi (RM)
La gestione del diabete
A. Secchi (MI)
Discussione
Ore 9.30-10.30
COMUNICAZIONI ORALI
Carcinoma del pancreas
Moderatori: G. Balzano (MI), S. Massironi (MI)
Aspirin, Statins, and Their Combined and The Risk of Pancreatic Cancer
L. Archibugi (RM)
Early detection of pancreatic cancer in high risk population: experience of a medical –nursing managed
screening ambulatory.
Palini
Familial Pancreatic Cancer In A Population Of Hospitalized Patients
Cosi
Dual Prognostic Significance of Tumor Associated Macrophages in Human Pancreatic Adenocarcinoma
Treated or not with Chemotherapy
G. Castino ()
THE MICRORNA PROCESSING ENDORIBONUCLEASE DICER HAS ALTERED EXPRESSION IN PANCREATIC
DUCTAL ADENOCARCINOMA AND PROGNOSTIC IMPLICATIONS
Frampton
Nab-Paclitaxel (Nab-P) and Gemcitabine (G) as First Line Chemotherapy (CT) in Advanced Pancreatic
Cancer (APDAC) Patients (pts): an Italian “Real Life” Study
Giordano
What role for stereotactic body radiotherapy (SBRT) in the treatment of pancreatic cancer? Clinical
results of a phase II study
Comito
Percutaneous Ultrasound-Guided Radiofrequency Ablation (RFA) of Pancreatic Ductal Adenocarcinoma
D'Onofrio
Ore 10.30-11.00 Break
Ore 11.00-11.30
AISP INCONTRA EPC: PANCREAS 2000
Moderatori: G. Capurso (RM), M. Del Chiaro (SVEZIA)
Storia del progetto
M. Del Chiaro (SVEZIA)
Prospettive attuali e future
G. Capurso (RM)
Esperienze vissute e discussione
Ore 11.30-12.00
PANCREATITE DA IPERTRIGLICERIDEMIA
Moderatori: E. Giovannetti (PI), P. A. Testoni (MI)
Incidenza, problematiche cliniche ed approccio terapeutico
L. Frulloni (VR)
Nuove possibilità terapeutiche: terapia genica nei pazienti portatori di mutazioni della lipoproteinlipasi
C. Zambon (PD)
Discussione
Ore 12.00-13.00
COMUNICAZIONI ORALI
Chirurgia del pancreas
Moderatori: P. De Rai (MI), L. Gianotti (MB)
Lymphadenectomy for periampullary cancer: prognostic role of different metastatic nodal stations and
of the number of metastatic lymph nodes
G. Nappo (RM)
Central Pancreatectomy: Experience with 129 consecutive Patients Treated in Two European Pancreatic
Centers
A.C. Milanetto (PD)
Pancreaticojejunostomy After Pancreaticoduodenectomy: Suture Material and Incidence of PostOperative Pancreatic Fistula
Andrianello
Preoperative Computed Tomography to Predict and Stratify the Risk of Severe Pancreatic Fistula after
Pancreatoduodenectomy
M. Sandini ()
C-Reactive Protein and Procalcitonin as Predictors of Postoperative Complications after
Pancreaticoduodenectomy: a Prospective Study
Giardino
Readmission After Pancreaticoduodenectomy In An Italian Setting
F. Uccelli (MI)
Spleen-Preserving Pancreatic Resections with Preservation of Splenic Vessels: a Cautionary Note on the
Risk of Vascular Complications
M. Bissolati (MI)
Laparoscopic distal pancreatectomy in benign or premalignant pancreatic lesions: is it really more costeffective than open approach?
G. Taffurelli ()
Ore 13.00-13.30
PREMIAZIONE E CHIUSURA CONGRESSO